Global pharmaceutical giant Eli Lilly is reportedly in advanced discussions to acquire psychedelic drug developer AtaiBeckley, in what would become ...
For much of the past decade, success in the cannabis and psychedelic sectors has been measured by one metric above ...
Australia has earned global recognition for its role in the emerging psychedelic medicines sector. The country's decision to permit authorised ...
Australian biotechnology company Entropy Neurodynamics (ASX: ENP) has reported encouraging topline results from the first cohort of its Phase 2 ...
Psychedelics.media delivers trusted news, intelligence, and insights for the global psychedelic medicine industry.
